Please login to the form below

Not currently logged in
Email:
Password:

Blue Rubicon

This page shows the latest Blue Rubicon news and features for those working in and with pharma, biotech and healthcare.

Controversial pancreatic cancer campaign wins award

Controversial pancreatic cancer campaign wins award

Sainsbury's, Sainsbury's by AMV BBDO, Blue Rubicon, PHD Media and Sainsbury's.

Latest news

  • Blue Rubicon buys Open Road Blue Rubicon buys Open Road

    We're bringing together two independent consultancies with a similar mind-set, approach, reputation and strategic communications offer,” said Blue Rubicon CEO, Gordon Tempest Hay. ... While forming part of the Blue Rubicon family, Open Road will

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Firstlight appoints three new directors Firstlight appoints three new directors

    All three joined Firstlight having excelled in leading agencies, Sam from Blue Rubicon, Anna from Cohn and Wolfe and Grant from Ruder Finn.

  • Edelman strengthens healthcare team Edelman strengthens healthcare team

    Dalton moves to the agency from Blue Rubicon, where she was a senior consultant, and also brings experience from Ogilvy &Mather and Weber Shandwick, where she most recently served as an

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Just::Health Communications

Just:: is a different kind of healthcare communications agency. Since 2006, we’ve been collaborating with clients around the world to...

Latest intelligence

China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...
Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...

Infographics